Evidence map›Paper›PMID 33737335›Full record

ArticleDisease models & mechanisms2021

Murine myeloid cell MCPIP1 suppresses autoimmunity by regulating B-cell expansion and differentiation.

Ewelina Dobosz, Georg Lorenz, Andrea Ribeiro, Vivian Würf, Marta Wadowska, Jerzy Kotlinowski, Christoph Schmaderer, Jan Potempa, Mingui Fu, Joanna Koziel and 1 more

Open access · goldAbstract read
In one paragraph

Article in Disease models & mechanisms, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Macrophage Zc3h12c Limits Tissue Inflammation and Injury via Alternative Splicing of Pre-mRNA.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Lupus Nephritis: Current Perspectives and Moving Forward.Journal of inflammation research · 2022
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Ewelina DoboszDepartment of Microbiology, Faculty of Biochemistry Biophysics and Biotechnology, Jagiellonian University, Krakow 30-387, Poland.ORCID 0000-0002-0151-9723
Georg LorenzKlinikum rechts der Isar, Department of Nephrology, Technical University Munich, Munich 81675, Germany.
Andrea RibeiroLMU Klinikum, Medizinische Klinik und Poliklinik IV, Ludwig-Maximilians-Universität München, Munich 80336, Germany.
Vivian WürfLMU Klinikum, Medizinische Klinik und Poliklinik IV, Ludwig-Maximilians-Universität München, Munich 80336, Germany.
Marta WadowskaDepartment of Microbiology, Faculty of Biochemistry Biophysics and Biotechnology, Jagiellonian University, Krakow 30-387, Poland.ORCID 0000-0003-1293-1091
Jerzy KotlinowskiDepartment of General Biochemistry, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow 30-387, Poland.ORCID 0000-0002-3133-3364
Christoph SchmadererKlinikum rechts der Isar, Department of Nephrology, Technical University Munich, Munich 81675, Germany.
Jan PotempaDepartment of Microbiology, Faculty of Biochemistry Biophysics and Biotechnology, Jagiellonian University, Krakow 30-387, Poland.ORCID 0000-0002-3600-7461
Mingui FuDepartment of Biomedical Science and Shock, Trauma Research Center, School of Medicine, University of Missouri-Kansas City, Kansas City, MO 64108, USA.
Joanna KozielDepartment of Microbiology, Faculty of Biochemistry Biophysics and Biotechnology, Jagiellonian University, Krakow 30-387, Poland joanna.koziel@uj.edu.pl maciej.lech@med.uni-muenchen.de.ORCID 0000-0003-3436-6425
Maciej LechDepartment of Microbiology, Faculty of Biochemistry Biophysics and Biotechnology, Jagiellonian University, Krakow 30-387, Poland joanna.koziel@uj.edu.pl maciej.lech@med.uni-muenchen.de.ORCID 0000-0002-4293-2733
Jagiellonian University · PLLMU Klinikum · DETUM Klinikum · DEUniversity of Missouri–Kansas City · US

Funding

Ribonuclease-mediated control of sepsis-induced systemic inflammationR15AI138116 · NIAID · UNIVERSITY OF MISSOURI KANSAS CITY · PI FU, MINGUI · 2019 to 2019
$465k
NIAID NIH HHS R15 AI138116
6 · The paper itself

Abstract

Myeloid-derived cells, in particular macrophages, are increasingly recognized as critical regulators of the balance of immunity and tolerance. However, whether they initiate autoimmune disease or perpetuate disease progression in terms of epiphenomena remains undefined.Here, we show that depletion of MCPIP1 in macrophages and granulocytes (

Indexed as

AutoimmunityCell DifferentiationAnimalsAntigen-Presenting CellsAutoantibodiesB-LymphocytesCell ProliferationCytokinesImmunosuppression TherapyInflammationInflammation MediatorsKidneyMacrophagesMiceMice, Inbred C57BLMyeloid CellsAutoantibodiesCytokinesInflammation MediatorsRibonucleasesRNA, MessengerToll-Like Receptor 7Toll-Like Receptor 9Zc3h12a protein, mouseAutoantibodiesAutoimmunityLupus nephritisMCPIP1Myeloid cells

Identifiers

PMID33737335
PMCPMC7988765
OpenAlexW3136645181

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.